Whereabouts in  are you from? http://chehrehsazan.ir/tagipharmacom-a292.pdf#youthful emedhouse.com
  Over the past few days the proxy battle became particularly hostile as each side accused the other of illegal or unethical practices. Some analysts called it the ugliest proxy fight yet in biotech, a field rife with activism from the likes of Carl Icahn and others.